These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Efficacy and tolerability of pregabalin in patients with difficult-to-treat epilepsy and intellectual disability. Huber B; Bocchicchio M; Feuerbaum E; May T; Meinert T; Robertson E; Schorlemmer H; Wagner W; Wilking E; Seidel M Epilepsy Behav; 2008 Aug; 13(2):397-401. PubMed ID: 18554985 [TBL] [Abstract][Full Text] [Related]
44. Topiramate slow dose titration: improved efficacy and tolerability. Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117 [TBL] [Abstract][Full Text] [Related]
45. Topiramate monotherapy in epilepsy and migraine prevention. Silberstein SD; Ben-Menachem E; Shank RP; Wiegand F Clin Ther; 2005 Feb; 27(2):154-65. PubMed ID: 15811478 [TBL] [Abstract][Full Text] [Related]
46. Topiramate and metabolic acidosis: a case series and review of the literature. Groeper K; McCann ME Paediatr Anaesth; 2005 Feb; 15(2):167-70. PubMed ID: 15675937 [TBL] [Abstract][Full Text] [Related]
47. Fatal heat stroke associated with topiramate therapy. Borron SW; Woolard R; Watts S Am J Emerg Med; 2013 Dec; 31(12):1720.e5-6. PubMed ID: 23993866 [TBL] [Abstract][Full Text] [Related]
48. Acute psychotic disorders induced by topiramate: report of two cases. Stella F; Caetano D; Cendes F; Guerreiro CA Arq Neuropsiquiatr; 2002 Jun; 60(2-A):285-7. PubMed ID: 12068361 [TBL] [Abstract][Full Text] [Related]
49. Palmar erythema due to topiramate. Scheinfeld N; Spahn C J Drugs Dermatol; 2004; 3(3):321-2. PubMed ID: 15176170 [TBL] [Abstract][Full Text] [Related]
50. Comprehensive management of epilepsy in persons with mental retardation. Coulter DL Epilepsia; 1997; 38 Suppl 4():S24-31. PubMed ID: 9240238 [TBL] [Abstract][Full Text] [Related]
51. Clinical guidelines for the management of epilepsy in adults with an intellectual disability. Working group of the International Association of the Scientific Study of Intellectual Disability Seizure; 2001 Sep; 10(6):401-9. PubMed ID: 11700992 [TBL] [Abstract][Full Text] [Related]
52. Acute mental status changes with topiramate. Brar B; Glazer JP; Franco K; Edwards T J Am Acad Child Adolesc Psychiatry; 2005 Aug; 44(8):725. PubMed ID: 16034273 [No Abstract] [Full Text] [Related]
53. [Expert opinion on topamax]. Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 2):57-8. PubMed ID: 22500334 [No Abstract] [Full Text] [Related]
56. Effects of rationalizing drug treatment of patients with epilepsy and mental retardation. Beghi E; Bollini P; Di Mascio R; Cerisola N; Merloni T; Manghi E Dev Med Child Neurol; 1987 Jun; 29(3):363-9. PubMed ID: 3596072 [TBL] [Abstract][Full Text] [Related]
58. Electronegative electroretinogram associated with topiramate toxicity and vitelliform maculopathy. Tsui I; Casper D; Chou CL; Tsang SH Doc Ophthalmol; 2008 Jan; 116(1):57-60. PubMed ID: 17912565 [TBL] [Abstract][Full Text] [Related]
59. Is there an association between topiramate and granuloma annulare? Ruzzetti M; Saraceno R; Peris K; Chimenti S J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):238-9. PubMed ID: 19682177 [No Abstract] [Full Text] [Related]
60. Panic attacks associated with the use of topiramate. Goldberg JF J Clin Psychopharmacol; 2001 Aug; 21(4):461-2. PubMed ID: 11476136 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]